Dispo Mediproducts India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 2.17 M
as on 18-07-2024
- Company Age 32 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 26.03%
(FY 2020)
- Profit -116.50%
(FY 2020)
- Ebitda -128.09%
(FY 2020)
- Net Worth -0.72%
(FY 2020)
- Total Assets -0.53%
(FY 2020)
About Dispo Mediproducts India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.17 M, as per Ministry of Corporate Affairs (MCA) records.
Divyakant Gupta, Chivukula Bharadwaj, and Janardhan Gaur serve as directors at the Company.
- CIN/LLPIN
U24231DL1992PLC049473
- Company No.
049473
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dispo Mediproducts India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divyakant Gupta  | Director | 22-May-2019 | Current |
| Chivukula Bharadwaj | Director | 31-Mar-1998 | Current |
| Janardhan Gaur | Director | 31-Mar-1998 | Current |
Financial Performance and Corporate Structure Insights of Dispo Mediproducts India.
Dispo Mediproducts India Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.03% increase. The company also saw a substantial fall in profitability, with a 116.5% decrease in profit. The company's net worth dipped by a decrease of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dispo Mediproducts India?
In 2020, Dispo Mediproducts India had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Idcube Identification Systems Private LimitedActive 19 years 2 daysDivyakant Gupta is a mutual person
Nucleus Software Workshop Private LimitedActive 38 years 1 monthChivukula Bharadwaj and Janardhan Gaur are mutual person
Card Systems Private LimitedActive 35 years 24 daysChivukula Bharadwaj and Janardhan Gaur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dispo Mediproducts India?
Dispo Mediproducts India has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dispo Mediproducts India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dispo Mediproducts India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
